Patent directory · USPTO A61K / A61P
Patents matching “The United States of America, As Represented By”
2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8790639
Enhanced antimicrobial lytic activity of a chimeric Ply187 endolysin
granted -
US 8790635
Live, oral vaccine for protection against Shigella dysenteriae serotype 1
granted -
US 8791074
Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors
granted -
US 8790869
Renal cell carcinoma biomarkers
granted -
US 8785414
Differentially expressed microRNAs as biomarkers for the diagnosis and treatment of Sjögren's syndrome
granted -
US 8785601
T cell receptors and related materials and methods of use
granted -
US 8785421
Use of vitamin D in dairy mastitis treatment
granted -
US 8778354
Compositions and methods for modulating RSV infection and immunity
granted -
US 8779095
LAT adapter molecule for enhanced T-cell signaling and method of use
granted -
US 8772256
Codon modified immunogenic compositions and methods of use
granted -
US 8765141
Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host
granted -
US 8759014
Methods of obtaining antigen-specific T cell populations
granted -
US 8754030
Defensin-antigen fusion proteins
granted -
US 8753649
Polysaccharide-protein conjugate vaccines
granted -
US 8754081
Compositions and methods for inhibition of hepatocyte growth factor receptor c-Met signaling
granted -
US 8754046
MHC class II restricted T cell epitopes from the cancer anitgen, NY ESO-1
granted -
US 8747859
Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142
granted -
US 8747823
Compositions and methods for treating a keratin based substrate
granted -
US 8748572
RNase a peptides, fragments and uses thereof
granted -
US 8748390
Immunogenic epitopes of NGEP antigen
granted -
US 8741313
Polypeptide vaccine and vaccination strategy against mycobacterium
granted -
US 8741309
Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142
granted -
US 8741649
Methods for enhancing genome stability and telomere elongation in embryonic stem cells
granted -
US 8735126
Disease control with tick phospholipase A2
granted